In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2266-2270

  Dubreuil, Luc ^a,b   Houcke, Isabelle ^a   Mouton, Yves ^b   Rossignol, Jean François ^c  

^a UNIV LILLE   (France)

^b Dron Hospital   (France)

^c Romark Institute for Medical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; NITAZOXANIDE; PIPERACILLIN; THIAZOLE DERIVATIVE;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; BACTEROIDES FRAGILIS; CLOSTRIDIUM; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; ENTEROBACTERIACEAE; ENTEROCOCCUS; LACTOBACILLUS BIFIDUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM; PSEUDOMONAS; STAPHYLOCOCCUS;

EID: 0029836681     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2266     Document Type: Article

References (20)

1. Abaza, H. Successful treatment of heavily infected human fascioliasis with the new broad spectrum antiparasitic-antibacterial nitazoxanide. Submitted for publication.
2. Bland, S., A. Sedallian, G. Grollier, F. Mory, I. Houcke, and L. Dubreuil. 1995. In vitro activity of three carbapenems biapenem, imipenem and meropenem and some other antibiotics against anaerobic bacteria. Pathol. Biol. 43:289-293.
3. Brazier, J. S., D. M. Citron, and E. J. C. Goldstein. 1991. A selective medium for Fusobacterium spp. J. Appl. Bacteriol. 71:343-346.
4. Dublanchet, A., J. Caillon, J. P. Edmond, H. Chardon, and H. B. Drugeon. 1986. Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles. Eur. J. Clin. Microbiol. 5:346-347.
5. Dubreuil, L., J. Breuil, A. Dublanchet, and A. Sedallian. 1992. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992. Eur. J. Clin. Microbiol. Infect. Dis. 11:1094-1099.
6. Ericsson, H. M., and J. C. Sherris. 1971. Antibiotic sensitivity testing: report of an international collaborative study. Acta Pathol. Microbiol. Scand. Sect. B Suppl. 217:65-73.
7. Euzeby, J., S. Prom Tep, and J. F. Rossignol. 1980. Experimentation des proprietes anthelminthiques de la nitazoxanide chez le chien, le chat et les ovins. Rev. Med. Vet. 131:687-696.
8. Grollier, G., F. Mory, C. Quentin, F. Girard-Pipau, S. Tigaud, A. Sedallian, and L. Dubreuil. 1994. Survey of anaerobic susceptibility patterns: a French multicentric study. Pathol. Biol. 42:498-504.
9. Kabil, S. M., F. Abd El-Salam, A. Nassar, and M. Abd El-Bast. 1994. Effects of nitazoxanide on the treatment of common human helminthic and protozoal infections. J. Trop. Med. (Egypt) 3:7-10.
10. Megraud, F., and J. F. Rossignol. A new compound of potential interest to eradicate Helicobacter pylori: nitazoxanide. Submitted for publication.
11. National Committee for Clinical Laboratory Standards. 1979. Reference dilution procedure for antimicrobial testing of anaerobic bacteria. Approved standard. NCCLS publication M-11T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial testing of anaerobic bacteria, 2nd ed. Approved standard. NCCLS publication M11-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
13. National Committee for Clinical Laboratory Standards. 1993. Approved standard M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Patey, O., E. Varon, T. Prazuck, I. Podglajen, A. Dublanchet, L. Dubreuil, and J. Breuil. 1994. Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the B. fragilis group. J. Antimicrob. Chemother. 33:1029-1035.
15. Quentin, C., J. L. Avril, C. Bebear, H. Dabernat, L. Dubreuil, M. Meyran, Y. Briand, and A. Sedallian. 1992. Comparative in vitro activity of meropenem on clinical isolates from France. Rev. Esp. Quimioter. 5(Suppl. 4):53-59.
16. Reysset, G., A. Haggoud, and M. Sebald. 1993. Genetics of resistance of Bacteroides species to 5-nitroimidazole. Clin. Infect. Dis. 16(Suppl. 4):S401-S403.
17. Rossignol, J. F. 1994. Nitazoxanide, a new broad spectrum antibacterial-antiparasiticidal drug: pre-clinical pharmacology. J. Trop. Med. (Egypt) 3:1-6.
18. Rossignol, J. F., and H. Maisonneuve. 1984. Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana. Am. J. Trop. Med. Hyg. 33:511-512.
19. Stockis, A., X. Deroubaix, R. Lins, B. Jeanbaptiste, P. Calderon, and J. F. Rossignol. 1996. Pharmacokinetics of nitazoxanide after single oral dose administration in 6 healthy volunteers. Int. J. Clin. Pharmacol. Ther. 34(8):349-351.
20. Wilkins, T. D., and S. Chalgren. 1976. Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob. Agents Chemother. 10:926-928.